Tower Research Capital LLC (TRC) - NEUROSENSE THERAPEUTICS LTD ownership

NEUROSENSE THERAPEUTICS LTD's ticker is and the CUSIP is M74240108. A total of 8 filers reported holding NEUROSENSE THERAPEUTICS LTD in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Tower Research Capital LLC (TRC) ownership history of NEUROSENSE THERAPEUTICS LTD
ValueSharesWeighting
Q2 2022$33,000
+3200.0%
9,794
+3164.7%
0.00%
Q1 2022$1,000
-66.7%
300
-77.3%
0.00%
Q4 2021$3,0001,3230.00%
Other shareholders
NEUROSENSE THERAPEUTICS LTD shareholders Q2 2022
NameSharesValueWeighting ↓
Vanguard Personalized Indexing Management, LLC 39,634$134,0000.01%
CLEAR STREET LLC 7,157$24,0000.00%
Tower Research Capital LLC (TRC) 9,794$33,0000.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
MILLENNIUM MANAGEMENT LLC 20,259$68,0000.00%
CITIGROUP INC 49,744$168,0000.00%
JANE STREET GROUP, LLC 77,249$261,0000.00%
UBS Group AG 13,428$45,0000.00%
View complete list of NEUROSENSE THERAPEUTICS LTD shareholders